SelectScience webinar to explore diagnostic excellence in GI pathogen testing

As molecular testing continues to transform the diagnosis of gastrointestinal (GI) infections, clinical laboratories face increasing pressure to balance rapid results with appropriate test utilization and interpretation.

To help laboratories and healthcare professionals navigate these challenges, SelectScience^® is hosting a live webinar: Diagnostic Excellence in the Use of GI Pathogen Panels, in collaboration with Danaher company, Cepheid, on July 15, 2026.

The webinar will bring together leading experts in clinical microbiology and molecular diagnostics to explore how principles of diagnostic excellence and diagnostic stewardship can support more effective use of GI pathogen panels, improving diagnostic confidence while helping to optimize patient management.

Advances in syndromic molecular testing have dramatically expanded the ability to detect gastrointestinal pathogens quickly and accurately. However, with broader testing capabilities come new challenges, including appropriate test selection, interpretation of co-detections, distinguishing colonization from active infection, and ensuring results are considered within the broader clinical context.

During this practical educational webinar, attendees will discover how laboratories can use stewardship principles and evidence-based testing strategies to improve the clinical value of GI diagnostics. Experts will share real-world perspectives on optimizing testing workflows, supporting clinical decision-making, and maximizing the impact of molecular diagnostic technologies.

Learn from experts in clinical diagnostics

The webinar will feature:

Donna M. Wolk, PhD, D(ABMM)
Division Chief, Molecular and Microbial Diagnostics and Development, Geisinger Diagnostic Medicine Institute

Dr. Christophe Martinaud, MD, PhD
Senior Director of Medical and Scientific Affairs, Cepheid

The discussion will be moderated by Colleen Knoth, PhD, Scientific Director, Infectious Disease & Acute Care, Danaher

Key learning objectives

Attendees will learn how to:

• Apply principles of appropriate test selection and interpretation to improve diagnostic accuracy.
• Understand the role of pre-test probability, predictive values, and clinical context in GI testing decisions.
• Implement practical diagnostic stewardship interventions to improve test utilization and clinical actionability.
• Evaluate the strengths and limitations of syndromic GI panels compared with targeted testing approaches.
• Support better patient outcomes through evidence-based molecular diagnostic strategies.

Who should attend?

This webinar will be of particular interest to:

• Clinical microbiologists
• Medical laboratory scientists
• Infectious disease professionals
• Laboratory directors and managers
• Molecular diagnostics specialists
• Healthcare professionals involved in gastrointestinal infection diagnosis and management

Reserve your place

The webinar will take place on Wednesday, July 15 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT.

Attendance is free, but registration is required. All attendees who join the live event will receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. Those unable to attend can access the on-demand recording following the webinar.

Register today to gain expert insights into GI pathogen testing, diagnostic stewardship, and practical strategies for improving diagnostic accuracy and clinical impact.